The U.S. Food and Drug Administration has no plans to put a "black box" warning on COVID-19 vaccines, Bloomberg News reported ...
A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after Covid mRNA vaccination, Stanford ...
Pfizer's COVID-19 vaccine has become the first in the U.S. to receive full approval from the FDA for people ages 16 and up.
Zacks Investment Research on MSN
BMY gains 13.1% in three months: Buy, sell or hold the stock?
Bristol Myers Squibb Company BMY has been performing well recently. Shares of this biotech giant have gained 13.1% in the ...
While BioNTech shares are currently trading near their 52-week lows, the Mainz-based biotechnology firm is signaling a significant operational shift. A major ...
A recent large-scale study has produced results that may challenge assumptions on Covid-19 vaccination. Examining health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback